Inhaled Pain Therapeutics: Evolving Therapeutics, Emerging Opportunities

‘Inhaled Pain Management: Evolving Therapeutics, Emerging Opportunities’ is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector.

The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for inhaled pain management drug therapeutics. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

User-friendly Administration for a Diverse and Growing Therapeutic Need

As life expectancy in the developed world increases and populations age, the incidence and associated morbidity of chronic and acute pain is increasing and placing a higher level of emphasis on pain management as a quality-of-life issue for patients and their families. Responding to this trend, drug developers are increasingly turning to inhalable formulations of pain management drugs. Because it has the potential to improve drug therapy compliance, inhaled pain drug delivery addresses a key healthcare issue - one that is particularly problematic in aging populations and developing economies. Several of these development programs involve international partnerships designed to take advantage of perceived opportunities in regional markets.

What You Will Learn:

• Analyzes and evaluates inhaled pain management drugs currently in development and assesses the market potential for existing and probable future products.

• Examines inhalation device technology for commercial and development-stage devices, and evaluates product technology issues and evolving market factors for inhaled pain management therapeutics.

• Provides detailed assessments of market segments, market potential, and growth prospects.

• Forecasts the impact of new and emerging inhaled pain management drug therapeutics on healthcare markets and prescribing decisions.

• Profiles Inhaled pain management drug product market participants, their technology, product development activity, and business strategies.

• Evaluates the impact of economic, technology, and regulatory factors on market sector companies and their alliance partners.